Cargando…

Evaluation of SARS-CoV-2 viral RNA in fecal samples

The need for timely establishment of a complete diagnostic protocol of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is demanded worldwide. We selected 15 positive novel coronavirus disease 19 (COVID-19) patients with mild or no symptom. Initially, fecal samples were negative in the 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesoraca, Alvaro, Margiotti, Katia, Viola, Antonella, Cima, Antonella, Sparacino, Davide, Giorlandino, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324771/
https://www.ncbi.nlm.nih.gov/pubmed/32605577
http://dx.doi.org/10.1186/s12985-020-01359-1
_version_ 1783552014087618560
author Mesoraca, Alvaro
Margiotti, Katia
Viola, Antonella
Cima, Antonella
Sparacino, Davide
Giorlandino, Claudio
author_facet Mesoraca, Alvaro
Margiotti, Katia
Viola, Antonella
Cima, Antonella
Sparacino, Davide
Giorlandino, Claudio
author_sort Mesoraca, Alvaro
collection PubMed
description The need for timely establishment of a complete diagnostic protocol of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is demanded worldwide. We selected 15 positive novel coronavirus disease 19 (COVID-19) patients with mild or no symptom. Initially, fecal samples were negative in the 67% (10/15) of the cases, while 33% (5/10) of the cases were positive. After serial virus RNA testing, 73% (11/15) of the cases resulted positive to fecal specimens. In particular, 15 days after the first positive respiratory specimens test, 6 fecal specimens became positive for SARS-CoV-2 RNA, while 13 respiratory test returned negative result. In conclusion, qRT-PCR assays of fecal specimens, is an important step to control infection, suggesting that samples remained positive for SARS-CoV-2 RNA longer time then respiratory tract samples. Our results enhance the recent knowledge on this emerging infectious disease and offer suggestions for a more complete diagnostic strategy.
format Online
Article
Text
id pubmed-7324771
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73247712020-06-30 Evaluation of SARS-CoV-2 viral RNA in fecal samples Mesoraca, Alvaro Margiotti, Katia Viola, Antonella Cima, Antonella Sparacino, Davide Giorlandino, Claudio Virol J Short Report The need for timely establishment of a complete diagnostic protocol of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is demanded worldwide. We selected 15 positive novel coronavirus disease 19 (COVID-19) patients with mild or no symptom. Initially, fecal samples were negative in the 67% (10/15) of the cases, while 33% (5/10) of the cases were positive. After serial virus RNA testing, 73% (11/15) of the cases resulted positive to fecal specimens. In particular, 15 days after the first positive respiratory specimens test, 6 fecal specimens became positive for SARS-CoV-2 RNA, while 13 respiratory test returned negative result. In conclusion, qRT-PCR assays of fecal specimens, is an important step to control infection, suggesting that samples remained positive for SARS-CoV-2 RNA longer time then respiratory tract samples. Our results enhance the recent knowledge on this emerging infectious disease and offer suggestions for a more complete diagnostic strategy. BioMed Central 2020-06-30 /pmc/articles/PMC7324771/ /pubmed/32605577 http://dx.doi.org/10.1186/s12985-020-01359-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Short Report
Mesoraca, Alvaro
Margiotti, Katia
Viola, Antonella
Cima, Antonella
Sparacino, Davide
Giorlandino, Claudio
Evaluation of SARS-CoV-2 viral RNA in fecal samples
title Evaluation of SARS-CoV-2 viral RNA in fecal samples
title_full Evaluation of SARS-CoV-2 viral RNA in fecal samples
title_fullStr Evaluation of SARS-CoV-2 viral RNA in fecal samples
title_full_unstemmed Evaluation of SARS-CoV-2 viral RNA in fecal samples
title_short Evaluation of SARS-CoV-2 viral RNA in fecal samples
title_sort evaluation of sars-cov-2 viral rna in fecal samples
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324771/
https://www.ncbi.nlm.nih.gov/pubmed/32605577
http://dx.doi.org/10.1186/s12985-020-01359-1
work_keys_str_mv AT mesoracaalvaro evaluationofsarscov2viralrnainfecalsamples
AT margiottikatia evaluationofsarscov2viralrnainfecalsamples
AT violaantonella evaluationofsarscov2viralrnainfecalsamples
AT cimaantonella evaluationofsarscov2viralrnainfecalsamples
AT sparacinodavide evaluationofsarscov2viralrnainfecalsamples
AT giorlandinoclaudio evaluationofsarscov2viralrnainfecalsamples